ADRs End Higher; WISeKey International Holding Ltd. Climbs 139%

Dow Jones16:31 ET

H.C. Wainwright Maintains Innate Pharma(IPHA.US) With Buy Rating, Maintains Target Price $11.5

Moomoo NewsDec 9 06:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target

BenzingaDec 9 06:30 ET

Innate Pharma SA Reveals Promising Lacutamab Trial Results

TipRanksDec 9 06:30 ET

Innate Pharma Analyst Ratings

BenzingaDec 9 06:24 ET · Ratings

Innate Pharma Announces New Data From TELLOMAK Study

TipRanksDec 9 05:35 ET